Stock listing

Anika Therapeutics Inc.

Selected listing: 889120 · LS · EUR · DE

Anika Therapeutics Inc. (Lang & Schwarz: 889120), Health Technology. Latest release Jul 29, 2026: Anika Reports Second Quarter 2026 Financial Results.

889120:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: 889120
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Anika Therapeutics Inc.

Anika Reports Second Quarter 2026 Financial Results

July 29, 2026

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

July 15, 2026

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

April 30, 2026

Anika Reports First Quarter 2026 Financial Results

April 29, 2026

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

April 16, 2026

All Anika Therapeutics Inc. news →

Events

Replays

Anika Therapeutics Inc. (ANIK) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:30 AM ET
Watch
Anika Therapeutics Inc. (ANIK) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 08:30 AM ET
Watch
Anika Therapeutics Inc. (ANIK) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Anika Therapeutics Inc.

Anika Therapeutics Inc. company profile

View the public company page for Anika Therapeutics Inc. on 6ix.

Anika Therapeutics Inc. news

Read company news and market updates connected to Anika Therapeutics Inc..

Anika Therapeutics Inc. investor events

Find investor webinars, events, and replay context for Anika Therapeutics Inc..